Bain Capital Life Sciences Investors, LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$1.8T
Holdings
31
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 5,831,307 | $429.0B | 24.30% | |
| 2 | AVIRATEA PHARMACEUTICALS, INC. | 5,615,659 | $346.8B | 19.64% | |
| 3 | ARQTARCUTIS BIOTHERAPEUTICS, INC. | 3,979,292 | $115.1B | 6.52% | |
| 4 | DVAXDYNAVAX TECHNOLOGIES CORP | 10,895,773 | $107.1B | 6.07% | |
| 5 | ANNXANNEXON INC | 3,241,628 | $90.2B | 5.11% | |
| 6 | PHVSPHARVARIS N.V. | 3,180,601 | $89.0B | 5.04% | |
| 7 | —DICERNA PHARMACEUTICALS INC | 3,080,237 | $78.8B | 4.46% | |
| 8 | CCCCC4 THERAPEUTICS, INC. | 1,642,209 | $60.7B | 3.44% | |
| 9 | —MERSANA THERAPEUTICS INC | 3,695,667 | $59.8B | 3.39% | |
| 10 | SLDBSOLID BIOSCIENCES INC | 7,929,918 | $43.9B | 2.48% | |
| 11 | —SYROS PHARMACEUTICALS, INC. | 5,785,036 | $43.3B | 2.45% | |
| 12 | NRIXNURIX THERAPEUTICS, INC. | 1,284,314 | $39.9B | 2.26% | |
| 13 | —CONSTELLATION PHARMACEUTICALS, INC. | 1,400,000 | $32.7B | 1.85% | |
| 14 | —APTINYX INC | 8,891,758 | $26.7B | 1.51% | |
| 15 | YB4PSAVARA INC | 11,622,598 | $24.2B | 1.37% | |
| 16 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $22.2B | 1.25% | |
| 17 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,700,000 | $21.4B | 1.21% | |
| 18 | KYMRKYMERA THERAPEUTICS INC. | 479,605 | $18.6B | 1.06% | |
| 19 | ASNSUSDX4 PHARMACEUTICALS INC | 2,119,540 | $18.2B | 1.03% | |
| 20 | CRNXCRINETICS PHARMACEUTICALS INC | 1,071,428 | $16.4B | 0.93% | |
| 21 | —BLUEBIRD BIO, INC. | 538,179 | $16.2B | 0.92% | |
| 22 | —ARYA SCIENCES ACQUISITION CORP III | 1,000,000 | $13.8B | 0.78% | |
| 23 | —THERAPEUTICS ACQUISITION CORP | 1,000,000 | $10.5B | 0.60% | |
| 24 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $10.3B | 0.58% | |
| 25 | —ARYA SCIENCES ACQUISITION CORP IV | 700,000 | $7.3B | 0.42% | |
| 26 | —BCTG ACQUISITION CORP | 500,000 | $5.6B | 0.31% | |
| 27 | —BCLS ACQUISITION CORP | 487,500 | $5.2B | 0.29% | |
| 28 | —OMEGA ALPHA SPAC | 400,000 | $4.0B | 0.22% | |
| 29 | —FRAZIER LIFESCIENCES ACQUISITION CORP | 300,000 | $3.0B | 0.17% | |
| 30 | —JIYA ACQUISITION CORP | 300,000 | $3.0B | 0.17% | |
| 31 | MLTXHELIX ACQUISITION CORP | 250,000 | $2.5B | 0.14% |